ID
32300
Descripción
Study ID: 109563 Clinical Study ID: 109563 Study Title: COMPAS:A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Patient Level Data: Study Listed on https://clinicaltrials.gov/ct2/show/NCT00466947 Clinicaltrials.gov Identifier: NCT00466947 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Trade Name: BIO 10PN-PD-DIT; Synflorix Study Indication: Infections, Streptococcal The Study consists of three workbooks. Workbook 1: Argentina, all subjects + immuno & reacto subset Workbook 2: Panama, all subjects + immuno & reacto subset + carriage subset + additional immuno subset Workbook 3: Colombia, all subjects The protocol number for all workbooks: 109563 (10Pn-PD-DiT-028) There are ten visits in workbook 1 and 2, eight for workbook 3 (there are no visits 4 and 7): Visit 1: month 0, dose 1, 6-16 weeks of age Visit 2: month 2, dose 2, +/- 4 months of age, 49-83 days after visit 1 Visit 3: month 4, dose 3, +/- 6 months of age, 49-83 days after visit 2 Visit 4: month 5, +/- 7 months of age, 28-42 days after visit 3. Only for immuno & reacto subset + carriage subset. Visit 5: month 10-13, 12-15 months of age Visit 6: month 13-16, booster dose, 15-18 months of age, ≥ 28 days after visit 5 Visit 7: month 14-17, 16-19 months of age, 28-42 days after visit 6. Only for immuno & reacto subset, additional immuno subset + carriage subset. Visit 8: month 16-19, 18-21 months of age, ≥ 28 days after visit 6 Visit 9: month 22-25, 24-27 months of age Visit 10: Contact This document contains the check for study continuation and elimination criteria which has to be filled in for Visit 2-9. It also contains physical examination which has to be filled in for Visit 2-4, 6, 9. It's for all workbooks. The document also contains the informed consent form for "all subjects and carriage subset". This item is only for workbook 2 and has to be filled in only for visit 6.
Link
https://clinicaltrials.gov/ct2/show/NCT00466947
Palabras clave
Versiones (3)
- 22/10/18 22/10/18 -
- 23/10/18 23/10/18 -
- 26/10/18 26/10/18 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
26 de octubre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Vaccination against pneumonia and otitis media, NCT00466947
Check for continuation, elimination criteria, physical examination
Descripción
CHECK FOR STUDY CONTINUATION
Alias
- UMLS CUI-1
- C0805733
- UMLS CUI-2
- C0008976
Descripción
If subject return to visit please complete the next pages
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0805733
Descripción
Please tick the ONE most appropriate reason and skip the following pages of this visit. If there is a SAE please complete and submit SAE report. If there is a AEX please complete Non-serious Adverse Event section. If there is an other reason for no return please specify in following item.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1298908
- UMLS CUI [1,2]
- C0545082
- UMLS CUI [1,3]
- C0805733
- UMLS CUI [1,4]
- C0566251
Descripción
Please complete and submit SAE report
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0237753
Descripción
Please complete Non-serious Adverse Event section
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0237753
Descripción
In workbook 1 and 2 only for immuno and reato subset.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0683368
- UMLS CUI [1,2]
- C1517001
- UMLS CUI [1,3]
- C1518404
- UMLS CUI [1,4]
- C0805701
Descripción
(e.g.: consent withdrawal, Protocol violation, …)
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3840932
- UMLS CUI [1,2]
- C1298908
- UMLS CUI [1,3]
- C0805733
Descripción
Decision made by Investigator, Parents/Guardians
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0008961
- UMLS CUI [2,1]
- C0679006
- UMLS CUI [2,2]
- C0030551
- UMLS CUI [2,3]
- C0023226
Descripción
ELIMINATION CRITERIA
Alias
- UMLS CUI-1
- C0680251
Descripción
Please tick all that applies in following items. Note: Please check exclusion criteria for further participation (only if subject returns at the visit)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1706839
Descripción
For Visit 3-9
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0445247
- UMLS CUI [1,3]
- C0205156
- UMLS CUI [1,4]
- C0545082
Descripción
Chronic administration is defined as more than 14 days
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0021081
- UMLS CUI [2,2]
- C0205191
- UMLS CUI [3]
- C0005525
Descripción
Elimination criteria: Major congenital defects/serious chronic illness.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0220810
- UMLS CUI [2,2]
- C0205164
- UMLS CUI [3,1]
- C0008679
- UMLS CUI [3,2]
- C0205404
Descripción
Elimination criteria: confirmed/suspected immunosuppressive/immunodeficient condition.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0750484
- UMLS CUI [2,2]
- C3829792
- UMLS CUI [3,1]
- C0750484
- UMLS CUI [3,2]
- C4048329
- UMLS CUI [4,1]
- C0242114
- UMLS CUI [4,2]
- C3829792
- UMLS CUI [5,1]
- C0242114
- UMLS CUI [5,2]
- C4048329
Descripción
Elimination criteria: immunoglobulins/any blood derived products
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2]
- C0021027
- UMLS CUI [3]
- C0456388
Descripción
Elimination criteria: use of investigational or non-registered product
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0680251
- UMLS CUI [2,1]
- C0304229
- UMLS CUI [2,2]
- C0332300
- UMLS CUI [2,3]
- C0042210
- UMLS CUI [2,4]
- C2348563
Descripción
Physical examination
Alias
- UMLS CUI-1
- C0031809
Descripción
ADDITIONAL IMMUNO ICF
Alias
- UMLS CUI-1
- C0021430
Descripción
If yes please complete blood sample question at this visit (if visit is performed) and perform Visit 7. Note: → All parents/guardians who signed their initial ICF of the group “All subjects” or “Carriage” and decided to be part of the Additional IR subgroup must answer “Yes” to this question. → All parents/guardians who did not perform Visit 6 must answer “NA” to this question.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0030551
- UMLS CUI [2,1]
- C0021430
- UMLS CUI [2,2]
- C0023226
Similar models
Check for continuation, elimination criteria, physical examination
C0008976 (UMLS CUI-2)
C0805733 (UMLS CUI [1,2])
C0545082 (UMLS CUI [1,2])
C0805733 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C1517001 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,4])
C1298908 (UMLS CUI [1,2])
C0805733 (UMLS CUI [1,3])
C0008961 (UMLS CUI [1,2])
C0679006 (UMLS CUI [2,1])
C0030551 (UMLS CUI [2,2])
C0023226 (UMLS CUI [2,3])
C1706839 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0545082 (UMLS CUI [1,4])
C0021081 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0005525 (UMLS CUI [3])
C0220810 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0008679 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0750484 (UMLS CUI [2,1])
C3829792 (UMLS CUI [2,2])
C0750484 (UMLS CUI [3,1])
C4048329 (UMLS CUI [3,2])
C0242114 (UMLS CUI [4,1])
C3829792 (UMLS CUI [4,2])
C0242114 (UMLS CUI [5,1])
C4048329 (UMLS CUI [5,2])
C0021027 (UMLS CUI [2])
C0456388 (UMLS CUI [3])
C0304229 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0042210 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
C0030551 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0023226 (UMLS CUI [2,2])